The US market dominated the North America Skin Cancer Diagnostics Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $3.35 billion by 2031. The Canada market is experiencing a CAGR of 7% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 6.1% during (2024 - 2031).
Technological advancements have profoundly impacted the skin cancer diagnostics market. The accuracy and efficacy of skin cancer detection have been improved by advancements in molecular diagnostics, artificial intelligence (AI), and imaging technologies.
Moreover, dermatoscopy, a non-invasive technique that uses a handheld device to examine skin lesions, has become a standard tool in dermatological practice. Confocal microscopy and high-frequency ultrasound offer detailed imaging at a cellular level, allowing for precise characterization of suspicious lesions.
In North America, the prevalence of skin cancer, particularly melanoma, is consistently increasing. This fuels the demand for accurate and efficient diagnostic tools. The United States has seen a significant rise in skin cancer cases, particularly melanoma, which is one of the most common types of cancer in the country. According to the American Cancer Society, about 100,640 new cases of melanoma are expected to be diagnosed in 2024, with approximately 8,290 deaths expected from the disease Factors contributing to the increased demand for skin cancer diagnostics include higher awareness and screening, increased exposure to ultraviolet (UV) radiation, and indoor tanning practices.
List of Key Companies Profiled
- Castle Biosciences, Inc.
- Bausch Health Companies, Inc. (DermTech, Inc.)
- Canfield Scientific, Inc.
- DermaSensor, Inc.
- F.Hoffmann-La Roche Ltd.
- NeoGenomics, Inc.
- Quest Diagnostics Incorporated.
- Digital Diagnostics, Inc. (3Derm Systems, Inc.)
- FotoFinder Systems GmbH
- Veriskin Inc
Market Report Segmentation
By Type- Non-Melanoma
- Melanoma
- Skin Biopsy
- Imaging Tests
- Dermatoscopy
- Lymph Node Biopsy
- Others
- Hospital & Clinics
- Laboratories
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Companies Mentioned
- Castle Biosciences, Inc.
- Bausch Health Companies, Inc. (DermTech, Inc.)
- Canfield Scientific, Inc.
- DermaSensor, Inc.
- F. Hoffmann-La Roche Ltd.
- NeoGenomics, Inc.
- Quest Diagnostics Incorporated.
- Digital Diagnostics, Inc. (3Derm Systems, Inc.)
- FotoFinder Systems GmbH
- Veriskin Inc
Methodology
LOADING...